Platelet activating factor is produced during infectious peritonitis in CAPD patients

Area of Science:

• Nephrology
• Immunology
• Biochemistry

Background:

• Peritonitis is a common complication in continuous ambulatory peritoneal dialysis (CAPD).
• Previous research implicated various mediators in peritoneal inflammation and increased permeability.
• The role of platelet-activating factor (PAF) in CAPD peritonitis was not fully understood.

Purpose of the Study:

• To investigate the presence and significance of platelet-activating factor (PAF) in the peritoneal dialysate during CAPD-related peritonitis.
• To determine the correlation between PAF levels and markers of inflammation and vascular permeability.

Main Methods:

• Lipid compounds were extracted from peritoneal dialysate of CAPD patients experiencing peritonitis (Group A) and healthy controls (Group B).
• Extracted compounds were analyzed for platelet-activating factor (PAF) presence and quantity.
• PAF levels were correlated with albumin loss and leukocyte counts in the dialysate.

Main Results:

• Significant amounts of PAF were detected in the dialysate of CAPD patients during peritonitis episodes.
• PAF levels showed a linear correlation with increased albumin loss and leukocyte counts.
• PAF was undetectable or present in minimal amounts in control patients and after peritonitis recovery.

Conclusions:

• This study provides the first direct evidence of local PAF generation during human peritoneal inflammation in CAPD.
• PAF likely contributes to increased peritoneal vascular permeability during septic inflammatory reactions.
• Understanding PAF's role may lead to new therapeutic strategies for CAPD peritonitis.